Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) shares were down 6.4% during mid-day trading on Tuesday . The company traded as low as $2.51 and last traded at $2.63, approximately 3,332,942 shares changed hands during mid-day trading. An increase of 139% from the average daily volume of 1,397,051 shares. The stock had previously closed at $2.81.
Separately, Zacks Investment Research upgraded Flagstar Bancorp from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research note on Monday, July 8th.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its earnings results on Tuesday, May 7th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.05). The company had revenue of $3.04 million during the quarter, compared to analysts’ expectations of $2.90 million.
About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.
Featured Article: Why do companies issue convertible shares?
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.